Recursion Pharmaceuticals Inc <RXRX.OQ> expected to post a loss of 43 cents a share - Earnings Preview

• Recursion Pharmaceuticals Inc RXRX.OQ RXRX.O is expected to show a rise in quarterly revenue when it reports results on February 28 for the period ending December 31 2024

• The Salt Lake City Utah-based company is expected to report a 74.8% increase in revenue to $19.043 million from $10.89 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Recursion Pharmaceuticals Inc is for a loss of 43 cents per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Recursion Pharmaceuticals Inc is $10.00​, above​ its last closing price of $8.14. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated February 26 at 13:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)